炎症性肠病病理诊断专家建议

2020-03-30 中华医学会消化病学分会炎症性肠病学组 中华消化杂志.2020.40(3):180-185.

病理在IBD诊断和鉴别诊断中的作用受到广泛关注,但仍存在观念、认识和实践上的问题和误区。本专家建议强调肠道炎症性疾病的病理诊断思路应从识别病变模式出发,每种模式提示一类可能的鉴别诊断。慢性肠炎是IBD

中文标题:

炎症性肠病病理诊断专家建议

发布日期:

2020-03-30

简要介绍:

病理在IBD诊断和鉴别诊断中的作用受到广泛关注,但仍存在观念、认识和实践上的问题和误区。本专家建议强调肠道炎症性疾病的病理诊断思路应从识别病变模式出发,每种模式提示一类可能的鉴别诊断。慢性肠炎是IBD的组织学模式,但IBD的诊断必须建立在慢性肠炎模式结合临床和系统性规范活组织检查的基础上。针对病理医师在IBD诊断和鉴别诊断中常引起困惑的问题提出专家建议,包括CD与UC、CD与肠结核、CD与肠道血管疾病,以及IBD与感染性肠炎之间的鉴别,也建议病理医师通过对诊断的病例主动随访反馈,在实践中不断积累诊断经验。

下载附件:

(因为版权问题,不支持下载)

评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=894643, encodeId=83db89464375, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d385159137, createdName=146b1a12m56暂无昵称, createdTime=Mon Oct 26 22:25:49 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894028, encodeId=fe52894028f3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6535428580, createdName=ms6000001925076547, createdTime=Fri Oct 23 22:02:13 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804244, encodeId=5711804244c1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoeEYicaoSDvLzl6Rtwiblf207icXFJnruGZBAHpLm6KiaqRbm38nWkZNpaLPGsVhRnR5WjJUOnqBCSyg/132, createdBy=b1702138478, createdName=街角对面的大米店, createdTime=Fri Jul 24 07:13:16 CST 2020, time=2020-07-24, status=1, ipAttribution=)]
    2020-10-26 146b1a12m56暂无昵称

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=894643, encodeId=83db89464375, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d385159137, createdName=146b1a12m56暂无昵称, createdTime=Mon Oct 26 22:25:49 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894028, encodeId=fe52894028f3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6535428580, createdName=ms6000001925076547, createdTime=Fri Oct 23 22:02:13 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804244, encodeId=5711804244c1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoeEYicaoSDvLzl6Rtwiblf207icXFJnruGZBAHpLm6KiaqRbm38nWkZNpaLPGsVhRnR5WjJUOnqBCSyg/132, createdBy=b1702138478, createdName=街角对面的大米店, createdTime=Fri Jul 24 07:13:16 CST 2020, time=2020-07-24, status=1, ipAttribution=)]
    2020-10-23 ms6000001925076547

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=894643, encodeId=83db89464375, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d385159137, createdName=146b1a12m56暂无昵称, createdTime=Mon Oct 26 22:25:49 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894028, encodeId=fe52894028f3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6535428580, createdName=ms6000001925076547, createdTime=Fri Oct 23 22:02:13 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804244, encodeId=5711804244c1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoeEYicaoSDvLzl6Rtwiblf207icXFJnruGZBAHpLm6KiaqRbm38nWkZNpaLPGsVhRnR5WjJUOnqBCSyg/132, createdBy=b1702138478, createdName=街角对面的大米店, createdTime=Fri Jul 24 07:13:16 CST 2020, time=2020-07-24, status=1, ipAttribution=)]
    2020-07-24 街角对面的大米店

    学习

    0

拓展阅读

2014年加拿大炎症性肠病(IBD)与静脉血栓防治共识意见:加拿大胃肠病学会

加拿大胃肠病学协会(CAG,The Canadian Association of Gastroenterology) · 2014-03-01

2014 ESPGHAN儿童和青少年炎症性肠病诊断的波尔图标准(修订版)

欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN,European Society for Paediatric Gastroenterology, Hepatology, and Nutrition) · 2014-06-10

2014 CAG立场声明:应用巯嘌呤类药物治疗炎症性肠病

加拿大胃肠病学协会(CAG,The Canadian Association of Gastroenterology) · 2014-07-04

2015 ASGE指南:内镜检查在炎症性肠病中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2015-03-20

2016 建立我国炎症性肠病诊治中心质量控制指标的共识

中华医学会消化病学分会炎症性肠病学组 · 2016-07-30

2017 IG-IBD临床实践指南:应用糖皮质激素和免疫抑制药物治疗炎症性肠病

意大利炎症性肠病研究组(IG-IBD,Italian Group for the Study of Inflammatory Bowel Disease) · 2017-01-25